Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator may live longer than those implanted with a traditional implantable cardioverter defibrillator, according to research.
Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator may live longer than those implanted with a traditional implantable cardioverter defibrillator, according to research.